Despite staff reductions related to the European Medicines Agency’s move from London to Amsterdam, there appears to be a consensus within the agency to continue revising the EU GMP guideline’s Annex 1 on the manufacture of sterile medicinal products, UK Medicines and Healthcare products Regulatory Agency inspector Andrew Hopkins said Oct. 15.
Hopkins, who serves as rapporteur for the guideline’s revision, indicated the revision will take a lot of work. The Annex...








